Recent Reports & Studies: GAO Finds Big Problems in NIH Royalty Income
With the rapid expansion of the research budget for the National Institutes of Health (NIH) and the high profile role of biotechnology in the New Economy, concerns have been raised in Congress as to whether or not NIH was keeping up on licensing and royalties. At the request of Congressmen Tom Bliley and Fred Upton, the General Accounting Office (GAO) has reviewed NIH’s internal controls.